PACS Group (NYSE:PACS) Stock: Insider Jason Hulse Murray Sells 232 Shares

Posted by Stephan Jacobs on Oct 18th, 2026

PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 232 shares of the business’s stock in a transaction dated Wednesday, October 14th. The stock was sold at an average price of $45.00, for a total transaction of $10,440.00. Following the transaction, the chief executive officer owned 54,435,017 shares in the company, valued at $2,449,575,765. This represents a 0.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total transaction of $402,875.82.
On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The shares were sold at an average price of $47.27, for a total transaction of $5,201,354.45.
On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The shares were sold at an average price of $42.48, for a total transaction of $30,458.16.
On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The shares were sold at an average price of $43.09, for a total transaction of $1,550,162.75.
On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The stock was sold at an average price of $42.66, for a total value of $1,033,395.84.
On Friday, October 2nd, Jason Murray sold 26,052 shares of PACS Group stock. The stock was sold at an average price of $42.51, for a total value of $1,107,470.52.
On Thursday, October 1st, Jason Murray sold 33,032 shares of PACS Group stock. The stock was sold at an average price of $41.13, for a total value of $1,358,606.16.
On Monday, September 14th, Jason Murray sold 317 shares of PACS Group stock. The shares were sold at an average price of $45.03, for a total value of $14,274.51.
On Friday, September 11th, Jason Murray sold 10,529 shares of PACS Group stock. The shares were sold at an average price of $45.23, for a total value of $476,226.67.
On Thursday, September 10th, Jason Murray sold 8,771 shares of PACS Group stock. The shares were sold at an average price of $45.16, for a total value of $396,098.36.

PACS Group Stock Performance

PACS opened at $46.93 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. PACS Group, Inc. has a 12-month low of $10.31 and a 12-month high of $49.49. The business has a 50 day moving average of $43.58 and a 200-day moving average of $40.42. The stock has a market cap of $7.43 billion, a price-to-earnings ratio of 27.28, a PEG ratio of 1.46 and a beta of -0.08.

PACS Group (NYSE:PACS – Get Free Report) last posted its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.09. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. On average, equities research analysts expect that PACS Group, Inc. will post 2.13 earnings per share for the current year.

More PACS Group News

Here are the key news stories impacting PACS Group this week:

Positive Sentiment: An analysis suggests that expanding the company’s lease portfolio could reshape the investment case for PACS Group, potentially supporting future growth and increasing investor interest. The article provides a potentially constructive strategic angle, although specific financial details were not included. Lease Expansion Could Reshape The Case For PACS Group Stock
Neutral Sentiment: PACS shares recently gained 6.2% on above-average volume, indicating strong near-term buying interest. However, Zacks cautioned that the latest earnings-estimate revision trend may not support additional gains in the immediate future, making continuation of the rally uncertain. PACS Group Surges 6.2%: Is This an Indication of Further Gains?
Negative Sentiment: CEO Jason Murray sold a combined 118,729 shares for approximately $5.60 million, while COO Joshua Jergensen sold 40,000 shares valued at $1.78 million. Such sales can weigh on sentiment because they indicate insider selling near recent highs; however, both executives retained substantial positions, and the transactions were made under pre-arranged trading plans.

Wall Street Analyst Weigh In

PACS has been the subject of a number of research analyst reports. UBS Group lifted their price objective on shares of PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 6th. Royal Bank Of Canada increased their price objective on shares of PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research report on Thursday, August 6th. JPMorgan Chase & Co. raised their target price on shares of PACS Group from $47.00 to $58.00 and gave the stock an “overweight” rating in a research note on Friday, September 4th. Oppenheimer lifted their target price on shares of PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Finally, Zacks Research downgraded shares of PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Five research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $58.80.

Check Out Our Latest Analysis on PACS

Hedge Funds Weigh In On PACS Group

A number of large investors have recently made changes to their positions in PACS. Dimensional Fund Advisors LP boosted its stake in PACS Group by 370.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock valued at $25,051,000 after purchasing an additional 614,250 shares during the period. Sei Investments Co. boosted its stake in PACS Group by 7.4% in the 1st quarter. Sei Investments Co. now owns 370,501 shares of the company’s stock valued at $11,900,000 after purchasing an additional 25,462 shares during the period. Arrowstreet Capital Limited Partnership grew its holdings in PACS Group by 44.6% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock valued at $9,274,000 after buying an additional 89,067 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in PACS Group in the 2nd quarter valued at $8,196,000. Finally, BI Asset Management Fondsmaeglerselskab A S acquired a new position in PACS Group in the 1st quarter valued at $6,762,000.

About PACS Group

(Get Free Report)

PACS Group, Inc is a healthcare services company that operates skilled nursing and other post-acute care facilities in the United States. Its facilities provide services for patients who require medical care, rehabilitation, recovery support, or assistance with daily activities following hospitalization or other acute health events.

The company’s services generally include skilled nursing, physical and occupational therapy, speech therapy, long-term care, short-term rehabilitation, and other specialized post-acute programs.